go back

Lisocabtagene Maraleucel (Breyanzi) CAR-T Therapy

Kansas rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $660,693 · 10th–90th $501,187$2,454,7090%10%20%10th90th$660,693Professionalmedian $562,341 · 10th–90th $562,341$676,0830%50%90th$562,341$100.0K$200.0K$500.0K$1.0M$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$660,693.45
Median
$1,122,018.45
Typical High
$2,454,708.92
Aetna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$602,559.59
Typical High
$794,328.23
BCBS
Setting
Facility
Modifier
Global
Typical Low
$501,187.23
Median
$524,807.46
Typical High
$524,807.46
BCBS
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$562,341.33
Cigna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$676,082.98
Medica
Setting
Facility
Modifier
Global
Typical Low
$478,630.09
Median
$630,957.34
Typical High
$1,348,962.88
Medica
Setting
Professional
Modifier
Global
Typical Low
$977,237.22
Median
$977,237.22
Typical High
$977,237.22
United
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$588,843.66
United
Setting
Professional
Modifier
Global
Typical Low
$346,736.85
Median
$512,861.38
Typical High
$660,693.45